Keywords: Aesica, UCB, Manufacturing plants, APIs

Aesica Pharma acquires UCB manufacturing sites in German and Italy

Article | 17 December 2010

UK-based Aesica Pharmaceuticals, a developer and manufacturer of active ingredients, has signed agreements ahead of acquiring three manufacturing sites in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aesica Pharmaceuticals

UCB

Go to company listing